NewsBite

Nanosonics delays product launch due to pandemic

Yolanda Redrup

Key Points

  • Revenue ($m) 100.1, up 18.7%
  • Pre-tax profit ($m) 12.4, down 26.2%
  • Net profit ($m) 10.1, down 25.7%
  • Final dividend (c) nil vs nil

Infection prevention medical device company Nanosonics has pushed back the launch date of its much-anticipated second product to 2022, as the business continues to grapple with the consequences of COVID-19.

On Tuesday the business revealed that fourth-quarter sales of its microwave-sized device called Trophon, which sterilises ultrasound probes without chemicals, had plummeted, as its sales representatives struggled to get access to hospitals in the US amid the pandemic.

Loading...
Yolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk. Connect with Yolanda on Twitter. Email Yolanda at yolanda.redrup@afr.com

Read More

Latest In Healthcare & fitness

Fetching latest articles

Most Viewed In Companies

    Original URL: https://www.afr.com/companies/healthcare-and-fitness/nanosonics-lifts-revenue-19pc-despite-q4-covid-crunch-20200824-p55ovu